Prime Therapeutics launches new MedsYourWay™ offering, now giving Blue Plan members home delivery prescription option using Amazon Pharmacy

October 6, 2021

EAGAN, Minn. – Prime Therapeutics LLC, a leading pharmacy benefit manager, announces its new MedsYourWay™ offering, designed to deliver breakthrough consumer shopping experiences for members of participating Blue Plans.

The first offering through MedsYourWay includes a new home delivery option using Amazon Pharmacy. Blue Plans will now have an additional home delivery option that they can choose to offer their members and clients. This new home delivery option with Amazon Pharmacy includes notable customer benefits, including simplified sign-up, real-time medication price displays and an integrated MedsYourWay prescription discount card administered by Inside Rx¹. Covered purchases with the MedsYourWay prescription discount card accrue toward a member’s out of pocket maximums and deductibles.

“MedsYourWay will challenge the traditional thinking in the PBM industry,” said Jarrod Henshaw, senior vice president, chief innovation and supply chain officer for Prime Therapeutics. “This umbrella offering is a reflection of what makes Prime Therapeutics so unique in the industry – true channel independence and an unbiased approach in identifying the best consumer solutions that allow our Blue Plan members to easily access low-cost medications. The first MedsYourWay offering for home delivery using Amazon Pharmacy is an excellent representation of this basic, but critical tenet of how we do business with our Blue Plan partners. We look forward to working with Amazon Pharmacy on the launch of the new offering.”

Over the coming months, additional breakthrough consumer shopping experiences will be launched by Prime Therapeutics under the MedsYourWay offering.


  1. Inside Rx, a subsidiary of Evernorth.

Related news

Press releases

October 18, 2021

Cancer patients, caregivers benefit with integrated clinic-to-pharmacy care through Prime Therapeutics’ IntegratedRx™ – Oncology

EAGAN, Minn. – Prime Therapeutics, a leading pharmacy benefit manager (PBM) serving more…

Press releases

October 14, 2021

In first of its kind study, Prime Therapeutics explores paroxysmal nocturnal hemoglobinuria (PNH) C5 inhibitor treatment rates

EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) used its…